Recent studies suggest that certain proteins may have properties that used to be thought specific to nucleic acids -they can transmit heritable traits in yeast and neurodegenerative diseases in mammals by a common mechanism, seeded protein polymerization.
Two inherited traits in yeast, called [PSI + ] and [URE3]
, have been known for almost thirty years to be inherited in a non-Mendelian manner [6] . trait is induced by mutation of the URE2 gene. The protein products of these two genes, Sup35 and Ure2, have essential functions; the former is a subunit of the translation terminator and the latter is involved in nitrogen metabolism. The sequences of the two proteins are not similar, but both contain amino-terminal domains that have unusual amino acid compositions and are not essential for their normal function. In either case, deletion of the amino-terminal domain prevents the inheritance of the trait, while its overexpression can induce the trait.
These and other factors led Wickner [13] to propose that these two proteins are analogous to the scrapie transmissible agent, in that all three may be transmitted by an abnormal form of a normal cellular protein (hence the designation 'yeast prions'). This analogy equates the 'dominant' traits [PSI + ] and [URE3] with the scrapie disease state, and holds that the conversion of a normal protein to an abnormal form induces the abnormal state. Before describing the recent evidence suggesting that this analogy can be extended to the mechanistic level, I shall briefly review the history of ideas regarding scrapie transmission, so that Wickner's inspiration can be more readily appreciated.
The abnormal physical properties of the scrapie infectious agent led several individuals to propose, in the early-tomid sixties, that the agent may contain only protein and no nucleic acid genome [2, 3] . In 1967, Griffith [1] suggested several mechanisms by which a 'protein-only' scrapie infectious agent could replicate; one of these involved seeded polymerization. Prusiner [14] and coworkers subsequently identified the primary protein constituent of the agent, and named it the prion protein (PrP). As no covalent differences have been identified between the normal cellular form of the prion protein (PrP C ) and the disease-associated form (PrP Sc ), it was proposed that the two forms are differentiated by their conformation [1, 15] . It is not clear, however, whether these differences involve secondary structure (helices, β-turns and so on), tertiary structure (overall fold), quarternary structure (oligomerization state) or a combination of these.
Griffith [1] proposed, as one among several possibilities, that PrP Sc is an ordered polymeric form of PrP, and that monomeric PrP C is slow to convert into PrP Sc because of the entropic barrier to nucleation of polymerization. According to this scenario, exogenous, or infective, PrP Sc can seed the polymerization of PrP C . We were drawn to this mechanistic possibility because of analogy with the process of amyloid formation: PrP Sc often exhibits properties of amyloid, and peptide fragments of PrP polymerize by a nucleation-dependent mechanism [11, 16] . However, although many amyloidogenic proteins, such as the amyloid β protein of Alzheimer's disease [17] , polymerize readily in vitro, PrP does not.
Rapid amyloid formation by amyloid β protein can be induced by seeding with preformed fibrils, and guided by this observation we were able to convert PrP C to a form that is biochemically indistinguishable from PrP Sc , using PrP Sc from infected brain as a seed [18] . This cell-free reaction exhibits all of the properties of scrapie transmission, including species barriers and strain-specificity [19] [20] [21] . The PrP Sc -derived in vitro seed is denser and has a larger hydrodynamic radius than denatured PrP, as would be expected of an oligomeric seed [22] , and is indistinguishable from scrapie infectivity -the in vivo seed? -in its sensitivity to denaturation [23] . So it seems possible that the in vitro conversion reaction mimics in vivo infection, and that both are seeded by an ordered PrP oligomer. The critical test of the 'protein-only' hypothesis would be to demonstrate that new infectivity is created from added PrP C in the cell-free conversion reaction.
In the case of the yeast prion, it has been much easier to bridge the in vitro studies and the biological phenomenon. The [PSI + ] trait has clearly been shown to be linked to the aggregation of Sup35 in the yeast cytoplasm [24] (scrapie is linked to the aggregation of PrP into a proteaseresistant form [2, 3] ). Three recent papers [7] [8] [9] have shown that Sup35 and its amino-terminal domain form amyloid fibrils in vitro by a nucleated polymerization mechanism. Lindquist and coworkers [7] showed that purified Sup35 and its isolated 'prion' domain form amyloid fibrils in vitro by a nucleated polymerization mechanism. This process could be seeded by preformed fibrils or by cytoplasm from [PSI + ] cells. Wuthrich and coworkers [8] reported similar studies of the Sup35 prion domain. And Ter-Avanesyan and coworkers [9] demonstrated that the cytoplasmic factor responsible for seeding the in vitro conversion of the normal, highly soluble form of the Sup35 protein to a denser, higher molecular weight form is a protein aggregate, consistent with its being a polymerization seed (the seed for in vitro PrP C -to-PrP Sc conversion has similar properties [22] ).
This seeded polymerization mechanism explains how treatment with a chemical denaturant can disaggregate the fibrillar form of Sup35 and restore the [PSI -] phenotype (Figure 1 ). Ter-Avanesyan and coworkers [9] demonstrated that the cytoplasm-derived [PSI + ] form could induce the conversion of 400-fold excess of the normal, monomeric form of Sup35 (a much more efficient version of the cell-free conversion of PrP C to PrP Sc [18] There is much work to be done to prove that protein polymerization seeds are involved in scrapie transmission and yeast inheritance -both phenomena that would typically be expected to require nucleic acid. The existence of a working mechanistic hypothesis, however, allows the design of diagnostic experiments, many of which are in progress. As a last comment, it is possible that there are additional examples of seeded protein polymerization that have gone unrecognized, not only in disease pathogenesis [10] but also in 'normal' biology [6] .
